Literature DB >> 2317412

High density lipoprotein cholesterol and triglycerides as markers of angiographically assessed coronary artery disease.

M Nikkilä1, T Koivula, K Niemelä, T Sisto.   

Abstract

Serum triglycerides, high density lipoprotein (HDL) cholesterol, and total cholesterol were measured in 698 patients examined by angiography. The ratio of HDL cholesterol to total cholesterol was significantly lower in patients with single, double, and triple vessel disease than in patients without disease. The serum concentration of triglyceride was significantly higher in patients with single, double, and triple vessel disease than in those without coronary artery disease. Similar proportion of patients with coronary artery disease and without had serum cholesterol concentrations of greater than or equal to 6.5 mmol/l, but total cholesterol was significantly higher in patients with single, double, and triple vessel disease than in those without. HDL cholesterol (less than 1.0 mmol/l), triglycerides (greater than 2.0 mmol/l), and the ratio of HDL cholesterol to total cholesterol (less than 0.20) were significantly better than total cholesterol as indicators of coronary risk.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2317412      PMCID: PMC1024330          DOI: 10.1136/hrt.63.2.78

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  21 in total

1.  Serum lipids in men with myocardial infarction.

Authors:  L A CARLSON
Journal:  Acta Med Scand       Date:  1960-08-31

2.  Serum cholesterol and triglycerides in patients suffering from ischemic heart disease and in healthy subjects.

Authors:  D Brunner; S Altman; K Loebl; S Schwartz; S Levin
Journal:  Atherosclerosis       Date:  1977-10       Impact factor: 5.162

3.  Serum triglycerides in health and in ischemic heart disease.

Authors:  D F Brown; S H Kinch; J T Doyle
Journal:  N Engl J Med       Date:  1965-10-28       Impact factor: 91.245

Review 4.  The pathogenesis of atherosclerosis--an update.

Authors:  R Ross
Journal:  N Engl J Med       Date:  1986-02-20       Impact factor: 91.245

5.  Relationship between lipids and occlusive coronary artery disease.

Authors:  A Zampogna; M H Luria; S J Manubens; M A Luria
Journal:  Arch Intern Med       Date:  1980-08

6.  Risk factors for ischaemic heart disease in men and women. Results of the 19-year follow-up of the Stockholm Prospective Study.

Authors:  L A Carlson; L E Böttiger
Journal:  Acta Med Scand       Date:  1985

7.  Serum triglycerides are a risk factor for myocardial infarction but not for angina pectoris. Results from a 10-year follow-up of Uppsala primary preventive study.

Authors:  H Aberg; H Lithell; I Selinus; H Hedstrand
Journal:  Atherosclerosis       Date:  1985-01       Impact factor: 5.162

8.  Triglycerides--main lipid risk factor for cardiovascular disease in women?

Authors:  L Lapidus; C Bengtsson; O Lindquist; J A Sigurdsson; E Rybo
Journal:  Acta Med Scand       Date:  1985

9.  The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study.

Authors:  N E Miller; D S Thelle; O H Forde; O D Mjos
Journal:  Lancet       Date:  1977-05-07       Impact factor: 79.321

10.  Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction.

Authors:  A Hamsten; B Wiman; U de Faire; M Blombäck
Journal:  N Engl J Med       Date:  1985-12-19       Impact factor: 91.245

View more
  3 in total

1.  Lecithin-cholesterol acryltransferase activity in patients with coronary artery disease examined by coronary angiography.

Authors:  N Solajić-Bozicević; A Stavljenić-Rukavina; M Sesto
Journal:  Clin Investig       Date:  1994-12

Review 2.  Pharmacological control of hypertriglyceridemia.

Authors:  G Franceschini; R Paoletti
Journal:  Cardiovasc Drugs Ther       Date:  1993-06       Impact factor: 3.727

Review 3.  Screening persons aged 65 and older for coronary heart disease risk factors.

Authors:  E W Kligman
Journal:  West J Med       Date:  1992-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.